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326a Monday, March 2, 2009regions within the exchanger’s cytoplasmic domain, of which the XIP region
shown to be involved in the rate and extent of Naþ-dependent inactivation
(I1). Although the XIP region is highly conserved amongst NCX isoforms, dis-
tinct I1 phenotypes exist. To better define the role of this region, we constructed
chimaeric NCX1:NCX2.1 proteins with their respective XIP regions inter-
changed as well as amino acid substitutions within the XIP region to examine
the more subtle aspects of phenotypic differences between NCX1.3 and
NCX2.1. Mutant exchangers were expressed in Xenopus oocytes, and outward
Naþ-Ca2þ exchange activity was assessed using the giant, excised patch clamp
technique. Substitution of the XIP region of NCX1.4 with the corresponding re-
gion from NCX2.1 caused an apparent loss of I1 whereas a reduction in the extent
of inactivation and a 15-fold increase in the rate of recovery from I1 were ob-
served in the NCX1.3 - XIP2 chimaera. Similarly, substitution of charged amino
acids within the XIP region in NCX1.3 caused a slight increase in the rate of re-
covery, equivalent to that observed for NCX2.1. Thus, non-conserved residues in
the XIP region may be essential in maintaining the structural stability of the Naþ-
dependent inactive state of NCX1. Furthermore, the XIP region must interact
with other regulatory domains of the protein, such as the mutually exclusive
exon, thereby contributing to the structure-function relationship as well as the
regulatory phenotype of each Naþ-Ca2þ exchanger variant and isoform.
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Phospholamban (PLN) is an integral membrane protein that regulates the Ca2þ
pump (SERCA2a) in cardiac sarcoplasmic reticulum (CSR). Phosphorylation
of PLN in response to b-adrenergic stimulation enhances cardiac inotropy by
increasing CSR Ca2þ uptake. Nitroxyl (HNO), a new candidate drug therapy
for congestive heart failure, improves overall cardiovascular function by in-
creasing Ca2þ release and re-uptake in CSR through a direct interaction with
RyR2 and SERCA2a, respectively. Using insect cell ER microsomes express-
ing SERCA2a þ/ PLN (WT and Cys/ Ala mutant) we have shown that
activation of SERCA2a by HNO is PLN-dependent and entails covalent mod-
ification of PLN cysteines. Although HNO stimulates SERCA2a activity by un-
coupling PLN from SERCA2a, the role of the cysteine residues in the activation
mechanism is not completely understood. We propose that HNO, a thiol oxi-
dant, modifies one or more of the three PLN cysteine residues (C36, C41,
C46), affecting the regulatory potency of PLN toward SERCA2a. Examples
include intra-molecular disulfide cross-links within single PLN molecules or
inter-molecular disulfide cross-links between PLN molecules or PLN and SER-
CA2a. To test this hypothesis, we have constructed a series of PLN mutants
containing single, double and triple cysteine substitutions (alanine replacing
cysteine). Each of these mutant PLNs will be co-expressed with SERCA2a
in insect cells and cell microsomes will be treated with Angeli’s salt (an
HNO donor) to determine which cysteine residue(s) are essential for activation
monitored by enzyme assay and fluorescence spectroscopy of SERCA2a. The
results show that intermolecular PLN disulfides play a minor role in activation
by HNO. Studies with the Cys/ Ala mutations will be useful in determining
which cysteine pairs in PLN contribute to intramolecular disulfide cross-links
leading to the relief of PLN inhibition and SERCA2a activation.
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Glycolipid transfer proteins (GLTPs) are small, soluble, ubiquitously expressed
proteins that selectively accelerate the intermembrane transfer of glycolipids
in vitro. Mammalian GLTPs (209 aa) are intrinsically fluorescent by virtue
of having three tryptophans and ten tyrosines. The crystal structure of human
GLTP (glycolipid-bound form) reveals the importance of W96 in the glycolipid
liganding site where its aromatic indole ring acts as a stacking platform that fa-
cilitates hydrogen bonding of the initial ceramide-linked sugar with Asp48,
Asn52, and Lys55. To gain insights into W96 functionality and to define the
role of the other two Trp residues (i.e., W85 & W142), three GLTP Trp mutants
(W96Y, W85Y-W96F, W96F-W142Y) were constructed by QuikChange
site-directed mutagenesis, overexpressed (pET-30) in E. coli, purified by metal
ion affinity and FPLC size exclusion chromatography, and characterized byglycolipid transfer activity measurements and by fluorescence and CD spec-
troscopy. Compared to wtGLTP, the single Trp mutant, W96Y, retained 65%
activity; whereas the double Trp mutants, W85Y-W96F & W96F-W142Y,
retained 22% and 110% activities. Quenching with acrylamide and potassium
iodide at physiological ionic strength resulted in linear Stern-Volmer plots,
suggesting accessibility of emitting Trp residues to soluble quenchers and con-
sistent with wtGLTP native folding. However, CD measurements revealed
significant differences in the secondary structure of W85Y-W96F-GLTP com-
pared to wtGLTP; whereas W96F-W142Y-GLTP and W96Y-GLTP retained
native secondary structure. We conclude that the negative consequences of con-
servative mutation of Trp 85 suggest a crucial role in proper folding of GLTP;
whereas, the tolerance of Trp96 and Trp142 for conservative, but not radical,
mutation is consistent with specialized roles in GLTP function, i.e. glycolipid
liganding and membrane interaction. [Support: NIH/NIGMS GM45928 &
GM34847, NIH/NCI CA121493, The Hormel & Mayo Foundations].
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Peritoneal macrophages express the P2X7 receptor, which opens a pore in the
membrane after long exposure with ATP, allowing passage of molecules up to
900 Daltons. It has been argued that activation of P2X7 receptor leads to open-
ing of an independent pore entity, not structurally related to the P2X7 receptor.
Based on results with connexin knock outs and pharmacological manipulation
with known gap junction blockers, some groups have included connexins and
pannexins, the gap junction-forming proteins in vertebrates, as reliable candi-
dates to provide for the large permeation pores associated with P2X7 activation.
In the present study we performed electrophysiological (whole cell patch
clamping recordings) and permeabilization assays (optical analysis and
FACS analysis) in which both efficacy and specificity of some gap junction
blockers were tested at conditions of putative P2X7R activation by ATP.
ATP generated a current in a nA levels that was blocked by well know P2X
blockers as BBG, KN-62 and oxidized ATP, in contrast the junction blockers
did not interfere with these effect. More than that, the up take assays showed
similar results to the patch clamp experiments, none of the junction blockers
was able to block the up take of ethidium bromide or propidium iodide. Our re-
sults indicate that well-known gap junction pharmacological blockers do not in-
terfere with current generation or dye uptake after activation of P2X7 receptor.
Taken together, our data strongly suggest that the high permeability pore evi-
dent at prolonged P2X7 activation does not correspond to connexin or pannexin
hemichannels in peritoneal macrophages.
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P-type ATPases are enzymes that stablish cation gradients across biologcal
membranes where ions are transported using the energy from hydrolysis of
ATP. The Na,K-ATPase and SERCA1a transport 3 Naþ/ 2 Kþ and Ca2þ , re-
spectively, against a concentration gradient for each ATP molecule hydrolyzed.
The two enzymes have very high sequence homology and show structural
similarities in the binding site of the ions. This raises questions concerning
the selectivity of the different structural basis and how each protein select its
specificion. The present study aims at characterising this selectivety.
In order to understand the specificity of the enzymes, we investigate the coor-
dination site in the two crystal structure of SERCA1a(PDB ID: 1SU4) and
Naþ/Kþ ATPase(PDB ID: 3B8) by constructing models of the active site.
The models are constructed using analogs of the amino acids from the first
and second solvation shell. We optimise the geometry of the models by con-
straining the C-alpha atoms using semi-empirical methods such as PM6 and
AM1. The energies and geometries are investigated further using ab initio, re-
stricted Hartree Fock, and density functional theory with the B3LYP functional
using the basis set 6-31G(d,p)*. We substitute Ca25ions into the binding
pocket of the Naþ/Kþ ATPase model to investigate how the specificity is re-
lated to the coordination environment. Furthermore, the protonation state of
side chains coordinating the ions are investigated in order to estimate the influ-
ence of pH changes on the binding of ions in the two pumps.
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